SHELL ASSET MANAGEMENT CO - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$498,000
-5.3%
11,265
-20.8%
0.02%
+18.8%
Q2 2022$526,000
+28.9%
14,216
+29.0%
0.02%
+60.0%
Q1 2022$408,000
+6.0%
11,022
-12.9%
0.01%
+25.0%
Q4 2021$385,000
-9.0%
12,651
+0.4%
0.01%
-11.1%
Q3 2021$423,000
-19.4%
12,603
-4.3%
0.01%
-10.0%
Q2 2021$525,000
-74.7%
13,169
-71.5%
0.01%
-75.6%
Q1 2021$2,074,000
+192.5%
46,133
+268.0%
0.04%
+173.3%
Q4 2020$709,000
+60.4%
12,536
+34.5%
0.02%
+50.0%
Q3 2020$442,000
-19.5%
9,3190.0%0.01%
-28.6%
Q2 2020$549,000
-15.8%
9,319
-32.4%
0.01%
-22.2%
Q1 2020$652,000
-22.5%
13,795
-0.9%
0.02%0.0%
Q4 2019$841,000
-16.7%
13,922
-17.4%
0.02%
-21.7%
Q3 2019$1,009,000
-7.2%
16,846
-0.4%
0.02%
-4.2%
Q2 2019$1,087,000
-5.1%
16,920
+19.9%
0.02%
-4.0%
Q1 2019$1,145,000
+50.1%
14,1120.0%0.02%
+31.6%
Q4 2018$763,000
-3.4%
14,112
-7.8%
0.02%
+18.8%
Q3 2018$790,000
+23.8%
15,3120.0%0.02%
+23.1%
Q2 2018$638,000
-10.3%
15,312
-5.1%
0.01%
-7.1%
Q1 2018$711,000
+746.4%
16,131
+602.6%
0.01%
+600.0%
Q3 2016$84,000
-34.4%
2,296
-58.4%
0.00%
-33.3%
Q2 2016$128,000
-48.4%
5,515
-10.1%
0.00%
-50.0%
Q1 2016$248,000
-34.7%
6,1330.0%0.01%
-33.3%
Q4 2015$380,0006,1330.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders